Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...
Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.
TOKYO - The Japanese government on Thursday is set to announce that the current COVID-19 quasi-emergency measures in place ...
With the recent contractions of hantavirus on a cruise ship, many are wondering how hantavirus differs from COVID-19.
An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, according to trial results published today in the New England Journal of ...
Doctors say the number of vaccinated mothers remains too low to show a measurable dip in infant hospitalisations.
Almost as soon as the hantavirus outbreak on the cruise ship MV Hondius became international news, public health experts ...
The first suspected 'generation-three' hantavirus case has emerged, potentially signifying the first stage of a wider ...
Scientists warn hantavirus may be as contagious as Covid as they identify 19 May as the critical date to discover whether the ...